Archives of Pediatric Infectious Diseases

Published by: Kowsar

Improving Outcomes for Adolescents With Drug-Resistant Tuberculosis

Lindsay McKenna 1 , * , Erica Lessem 1 and Loyce Maturu 2
Authors Information
1 Treatment Action Group, TB/HIV Project, New York, USA
2 Africaid Zvandiri Program, Harare, Zimbabwe
Article information
  • Archives of Pediatric Infectious Diseases: July 01, 2015, 3 (3); e29988
  • Published Online: July 14, 2015
  • Article Type: Letter
  • Received: May 29, 2015
  • Revised: May 31, 2015
  • Accepted: May 31, 2015
  • DOI: 10.5812/pedinfect.29988v2

To Cite: McKenna L, Lessem E, Maturu L. Improving Outcomes for Adolescents With Drug-Resistant Tuberculosis, Arch Pediatr Infect Dis. 2015 ; 3(3):e29988. doi: 10.5812/pedinfect.29988v2.

Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Moyo S, Furin JJ, Hughes J, Daniels J, Snyman L, Muller O, et al. Outcomes in Adolescents Undergoing Treatment for Drug-Resistant Tuberculosis in Cape Town, South Africa, 2008-2013. Arch Pediatr. 2014; 3(3)
  • 2. Snow KSBL. The epidemiology of TB, TB/HIV and MDR-TB in adolescents: what is the extent of the problem? 45th Union World Conference on Lung Health. 2014;
  • 3. Nachman S, Ahmed A, Amanullah F, Becerra MC, Botgros R, Brigden G, et al. Towards early inclusion of children in tuberculosis drugs trials: a consensus statement. Lancet Infect Dis. 2015; 15(6): 711-20[DOI]
  • 4. McKenna L. i-base/Treatment Action Group. 2015 pipeline report. 2015;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments